CRIS has great potential to rise to $10 and higher. Roche submitted the IND given the huge potential for the NEW drug. Expect more news on this topic in coming weeks and months. CRIS should already be trading back at $2.50. Shorts get ready to cover!
Roth is scum and the kiss of death for the share price once they are involved, pump the s/p just before a secondary offering is announced. Oh and of course while their pals are shorting before the offering announcement
Poster of Bernie in everyone's office is mandatory
Have to agree on that one, look at the analysts record. Close to the bottom of over 3 thousand who have been ranked. I am very looooong on Curis, but this analyst looks to be wrong way more than right. Studies have shown that analysts are no better than chance....do your own diligence...Curis is finally looking good again. Golf